Finance

Beta
Lists
OSTX:NYSEAMERICAN
OS Therapies Inc
USD 1,93
+10,60%
(+0,18) 1D
USD 1,93
-0,16% (-0,0030)
After hours
Closed: 18 Jun., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OSTX...
Open
USD 1,76
High
USD 1,96
Low
USD 1,74
Mkt. cap
85,96 m
Avg. vol.
705,61 k
Volume
1,15 m
52-wk high
USD 2,57
52-wk low
USD 1,15
EPS
-USD 1,05
Shares outstanding
44,54 m
No. of employees
4
Open
USD 1,76
High
USD 1,96
Low
USD 1,74
Mkt. cap
85,96 m
Avg. vol.
705,61 k
Volume
1,15 m
52-wk high
USD 2,57
52-wk low
USD 1,15
EPS
-USD 1,05
Shares outstanding
44,54 m
No. of employees
4
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to OSTX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for OSTX in the last 3 months.
Highest
Current USD 1,93
USD 13,00 (+573,58%)
Average
USD 9,50 (+392,23%)
Lowest
USD 6,00 (+210,88%)
News stories
From sources across the web
About OS Therapies Inc
CEO-
Employees4
Founded2018
HeadquartersRockville, Maryland, Verenigde State van Amerika
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,50 m
3,76 m
8,80 m
7,35 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,34 m
3,12 m
3,19 m
2,82 m
Operating expense
4,84 m
6,88 m
11,99 m
10,17 m
Total operating expenses
4,84 m
6,88 m
11,99 m
10,17 m
Operating income
-4,84 m
-6,88 m
-11,99 m
-10,17 m
Other non operating income
302,04 k
-
-1,47 m
-153,59 k
EBT including unusual items
-4,54 m
-6,88 m
-13,46 m
-10,40 m
EBT excluding unusual items
-4,54 m
-6,88 m
-13,46 m
-10,40 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,54 m
-6,88 m
-13,46 m
-10,40 m
Net profit margin
-
-
-
-
Earnings per share
-0,19
-0,21
-0,41
-0,27
Interest and investment income
64,00
65,00
54,00
45,00
Interest expense
-
-
-
-75,34 k
Net interest expenses
64,00
65,00
54,00
-75,30 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,73 m
-6,75 m
-11,86 m
-10,04 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more